| Gebro Pharma AG - Tavegyl, Injektionslösung |
| 35501 | | 01 | | Tavegyl | | Injektionslösung | | R06AA04 | | Clemastine | | 03.06.1970 | | |
|
| Composition |
| clemastinum 2 mg ut clemastini fumaras 2.68 mg, sorbitolum 90 mg, ethanolum 96 per centum 140 mg, propylenglycolum 600 mg, natrii citras dihydricus corresp. natrium 0.56 mg, aqua ad iniectabile q.s. ad solutionem pro 2 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Clemastine | 2mg / 2ml |
| | BAG: Active Agent | Dose |
|---|
| Clemastine | 2 mg |
| | | | Inactive agents | Dose |
|---|
| Ethanolum 96 Per Centum | 140mg / 2ml | | Natrii Citras Dihydricus | | | Propylenglycol | 600mg / 2ml | | Sorbitol | 90mg / 2ml |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 029 | 5 ampoule(s) | 7.41 | 17.30 | B | SL | No |
|
